GSK and Dr Reddy's form alliance for emerging markets
This article was originally published in Scrip
Executive Summary
Large innovator companies continue to tap leading Indian firms as they target emerging markets for growth in the short-term. GlaxoSmithKline and Dr Reddy's Laboratories are the latest to enter into an alliance to develop and market a basket of products across a large number of emerging markets, excluding India.